|
26 Companies |
|
28 Products |
|
28 Products |
|
26 Mechanisms of Action |
|
1 Trial |
|
237 News |
|
| «12345» |
- lidocaine topical / Generic mfg.
Enrollment open: Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia (clinicaltrials.gov) - Apr 13, 2014
P4, N=224, Recruiting, Sponsor: Universit
Not yet recruiting --> Recruiting
- lidocaine topical / Generic mfg.
Trial completion: Therapy to Prevent Sexual Pain in Breast Cancer Survivors (clinicaltrials.gov) - Apr 7, 2014
P3, N=50, Completed, Sponsor: Oregon Health and Science University
Not yet recruiting --> Recruiting Recruiting --> Completed
- New P1 trial: Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men (clinicaltrials.gov) - Apr 6, 2014
P1, N=45, Not yet recruiting, Sponsor: Baylor College of Medicine
- ||||| New P2 trial: Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder (clinicaltrials.gov) - Mar 31, 2014
P2, N=80, Active, not recruiting, Sponsor: Emotional Brain NY Inc.
- ||| Enrollment change: Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems (clinicaltrials.gov) - Mar 27, 2014
P2, N=207, Completed, Sponsor: Emotional Brain NY Inc.
Recruiting --> Completed N=80 --> 207
- |||| Trial completion: Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems (clinicaltrials.gov) - Mar 27, 2014
P2, N=207, Completed, Sponsor: Emotional Brain NY Inc.
N=80 --> 207 Active, not recruiting --> Completed
- Trial termination: INDEED: Pudendal Assessment in Erectile Dysfunction (clinicaltrials.gov) - Mar 12, 2014
P=N/A, N=10, Terminated, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Enrolling by invitation --> Terminated; data suggesting pudendal artery stenosis rarely being cause of ED
- Enrollment change: INDEED: Pudendal Assessment in Erectile Dysfunction (clinicaltrials.gov) - Mar 12, 2014
P=N/A, N=10, Terminated, Sponsor: University of Pennsylvania
Enrolling by invitation --> Terminated; data suggesting pudendal artery stenosis rarely being cause of ED N=200 --> 10
- ||||| New P1/2 trial, Stroma: Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction (clinicaltrials.gov) - Mar 12, 2014
P1/2, N=500, Recruiting, Sponsor: Ageless Regenerative Institute
- ||| Vyleesi (bremelanotide) / Palatin Technologies
Enrollment change: Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder (clinicaltrials.gov) - Mar 6, 2014
P2, N=612, Completed, Sponsor: Palatin Technologies
N=200 --> 10 N=400 --> 612
- |||| Vyleesi (bremelanotide) / Palatin Technologies
Trial completion: Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder (clinicaltrials.gov) - Mar 6, 2014
P2, N=612, Completed, Sponsor: Palatin Technologies
N=400 --> 612 Active, not recruiting --> Completed
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Trial withdrawal: Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction (clinicaltrials.gov) - Mar 2, 2014
P4, N=0, Withdrawn, Sponsor: Lawson Health Research Institute
Active, not recruiting --> Completed Enrolling by invitation --> Withdrawn
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Enrollment change: Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction (clinicaltrials.gov) - Mar 2, 2014
P4, N=0, Withdrawn, Sponsor: Lawson Health Research Institute
Enrolling by invitation --> Withdrawn N=100 --> 0
- ||||||| NN1213 / Novo Nordisk
Trial completion: Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido (clinicaltrials.gov) - Feb 22, 2014
P3, N=814, Completed, Sponsor: Warner Chilcott
N=100 --> 0 No longer recruiting --> Completed
- ||||||| NN1213 / Novo Nordisk
Trial completion: Zestra in Women With Mixed Sexual Dysfunction (clinicaltrials.gov) - Feb 22, 2014
P3, N=200, Completed, Sponsor: QualiLife Pharmaceuticals
No longer recruiting --> Completed No longer recruiting --> Completed
- |||| tacrolimus intravenous / Generic mfg.
Trial completion: A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy (clinicaltrials.gov) - Feb 22, 2014
P4, N=131, Completed, Sponsor: Astellas Pharma Inc
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=111, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P3 trial: Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT) (clinicaltrials.gov) - Feb 19, 2014
P3, N=40, Terminated, Sponsor: Storz Medical AG
- Nebido (testosterone undecanoate depot injection) / Bayer
Enrollment change: Sex Steroids and the Serotonin Transporter (clinicaltrials.gov) - Jan 1, 2014
P4, N=32, Completed, Sponsor: Medical University of Vienna
Active, not recruiting --> Completed N=20 --> 32
- Nebido (testosterone undecanoate depot injection) / Bayer
Trial completion: Sex Steroids and the Serotonin Transporter (clinicaltrials.gov) - Jan 1, 2014
P4, N=32, Completed, Sponsor: Medical University of Vienna
N=20 --> 32 Recruiting --> Completed
- Trial initiation date: Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=40, Recruiting, Sponsor: Initia
Recruiting --> Completed Initiation date: May 2013 --> Oct 2013
- Enrollment open: Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=40, Recruiting, Sponsor: Initia
Initiation date: May 2013 --> Oct 2013 Not yet recruiting --> Recruiting
- ||| Clinical: LISW: Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction (clinicaltrials.gov) - Dec 5, 2013
P=N/A, N=58, Completed, Sponsor: Initia
- || Enrollment closed: Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' for Patients With Erectile Dysfunction (clinicaltrials.gov) - Dec 3, 2013
P=N/A, N=60, Active, not recruiting, Sponsor: Initia
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion, Surgery: Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery (clinicaltrials.gov) - Nov 21, 2013
P=N/A, N=50, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||||| Stendra (avanafil) / IEH Biopharma, Menarini, Endo
Trial completion: This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction. (clinicaltrials.gov) - Nov 17, 2013
P3, N=195, Completed, Sponsor: JW Pharmaceutical
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P4 trial: Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder (clinicaltrials.gov) - Nov 3, 2013
P4, N=44, Recruiting, Sponsor: Federal University of Minas Gerais
- ||| Stendra (avanafil) / IEH Biopharma, Menarini, Endo
Enrollment closed: Study Evaluating the Effects of Avanafil on Semen Parameters (clinicaltrials.gov) - Oct 22, 2013
P4, N=220, Active, not recruiting, Sponsor: VIVUS, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Zydena (udenafil) / Mezzion
New P2 trial: Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction (clinicaltrials.gov) - Oct 20, 2013
P2, N=950, Not yet recruiting, Sponsor: Takeda
- ||| Zydena (udenafil) / Mezzion
New P1 trial: Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults (clinicaltrials.gov) - Oct 20, 2013
P1, N=83, Completed, Sponsor: Takeda
- |||||| tadalafil / Generic mfg.
Enrollment open: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) (clinicaltrials.gov) - Oct 8, 2013
P3, N=890, Recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Adverse events: Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions (clinicaltrials.gov) - Sep 29, 2013
P=N/A, N=3000, Recruiting, Sponsor: Elliot Lander
- ||| tadalafil / Generic mfg.
Enrollment change: REACTT: A Study of Tadalafil After Radical Prostatectomy (clinicaltrials.gov) - Sep 9, 2013
P4, N=583, Completed, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting N=412 --> 583
- sildenafil / Generic mfg.
New P4 trial: Motor Response to Sildenafil in PD (clinicaltrials.gov) - Sep 9, 2013
P4, N=8, Completed, Sponsor: Bispebjerg Hospital
- sildenafil / Generic mfg.
Trial completion: Motor Response to Sildenafil in PD (clinicaltrials.gov) - Sep 9, 2013
P4, N=8, Completed, Sponsor: Bispebjerg Hospital
N=412 --> 583 Not yet recruiting --> Completed
- |||||||||| tadalafil / Generic mfg.
New P3 trial: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) (clinicaltrials.gov) - Sep 8, 2013
P3, N=890, Recruiting, Sponsor: Eli Lilly and Company
- | lidocaine topical / Generic mfg.
New P4 trial: Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia (clinicaltrials.gov) - Sep 2, 2013
P4, N=224, Recruiting, Sponsor: Universit
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Trial initiation date: Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction (clinicaltrials.gov) - Aug 26, 2013
P4, N=0, Withdrawn, Sponsor: Lawson Health Research Institute
Not yet recruiting --> Completed Initiation date: Jan 2013 --> Dec 2013
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Trial termination: Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction (clinicaltrials.gov) - Aug 4, 2013
P2, N=16, Terminated, Sponsor: Warner Chilcott
Initiation date: Jan 2013 --> Dec 2013 Suspended --> Terminated; Re-assessment of study
- Vitaros (alprostadil + novel excipient) / Seelos Therap
Enrollment change: Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction (clinicaltrials.gov) - Aug 4, 2013
P2, N=16, Terminated, Sponsor: Warner Chilcott
Suspended --> Terminated; Re-assessment of study N=30 --> 16
- ||||| Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
New P2 trial: A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation (clinicaltrials.gov) - Aug 4, 2013
P2, N=60, Recruiting, Sponsor: Allergan
- Enrollment change: Erectile Dysfunction Study (clinicaltrials.gov) - Jul 30, 2013
P=N/A, N=64, Completed, Sponsor: Duke University
N=30 --> 16 N=50 --> 64
- Trial completion: Erectile Dysfunction Study (clinicaltrials.gov) - Jul 30, 2013
P=N/A, N=64, Completed, Sponsor: Duke University
N=50 --> 64 Recruiting --> Completed
- | sildenafil / Generic mfg.
New P4 trial: Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer (clinicaltrials.gov) - Jul 29, 2013
P4, N=90, Recruiting, Sponsor: Nanfang Hospital of Southern Medical University
- |||| sildenafil / Generic mfg.
Trial completion: Lybrido for Female Sexual Dysfunction (clinicaltrials.gov) - Jul 25, 2013
P2, N=196, Completed, Sponsor: Emotional Brain NY Inc.
Recruiting --> Completed Recruiting --> Completed
- Enrollment open: EPIPARA: Descriptive Epidemiology Study for Patients With Paraphilia Sex Offenders and Receiving Androgen Antagonists (clinicaltrials.gov) - Jul 21, 2013
P=N/A, N=200, Recruiting, Sponsor: University Hospital, Rouen
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Zydena (udenafil) / Mezzion
New P3 trial: Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction (clinicaltrials.gov) - Jul 15, 2013
P3, N=302, Completed, Sponsor: Dong-A Pharmaceutical Co., Ltd.
- ||| Stendra (avanafil) / IEH Biopharma, Menarini, Endo
Enrollment change: Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction (clinicaltrials.gov) - Jul 11, 2013
P4, N=440, Completed, Sponsor: VIVUS, Inc.
Not yet recruiting --> Recruiting N=300 --> 440
- | Trial completion: Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Preservation and Restoration of Urinary Continence and Erectile Function and in the Treatment of Erectile Dysfunction and Urinary Incontinence in Conjunction With Nerve Sparing Radical Prostatectomy (clinicaltrials.gov) - May 22, 2013
P3, N=68, Completed, Sponsor: Copenhagen University Hospital at Herlev
N=300 --> 440 Active, not recruiting --> Completed
- Botox (onabotulinumtoxin A) / GSK, AbbVie
Clinical: VginsmsBOTOX: Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm (clinicaltrials.gov) - May 20, 2013
P=N/A, N=20, Recruiting, Sponsor: Abdel-Maguid Ramzy